Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Organ Preservation With Active Surveillance After Chemoradiation in Rectal Cancer (OPTION)

NCT03594630 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT03594630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03594630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Organ Preservation With Active Surveillance After Chemoradiation in Rectal Cancer (OPTION)
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1
Overall status
Recruiting
Start date
March 13, 2024
Completion date
October 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rectal adenocarcinoma, stage ii rectal cancer ajcc v8, stage iia rectal cancer ajcc v8, stage iib rectal cancer ajcc v8, stage iic rectal cancer ajcc v8, stage iii rectal cancer ajcc v8, stage iiia rectal cancer ajcc v8, stage iiib rectal cancer ajcc v8, stage iiic rectal cancer ajcc v8